1112 related articles for article (PubMed ID: 18510351)
21. Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression.
Wilson AC; Salamat MS; Haasl RJ; Roche KM; Karande A; Meethal SV; Terasawa E; Bowen RL; Atwood CS
J Endocrinol; 2006 Dec; 191(3):651-63. PubMed ID: 17170222
[TBL] [Abstract][Full Text] [Related]
22. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
23. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
[TBL] [Abstract][Full Text] [Related]
24. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
[TBL] [Abstract][Full Text] [Related]
25. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
26. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
Engel JB; Keller G; Schally AV; Nagy A; Chism DD; Halmos G
Fertil Steril; 2005 Apr; 83 Suppl 1():1125-33. PubMed ID: 15831285
[TBL] [Abstract][Full Text] [Related]
27. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor.
Chatzaki E; Bax CM; Eidne KA; Anderson L; Grudzinskas JG; Gallagher CJ
Cancer Res; 1996 May; 56(9):2059-65. PubMed ID: 8616851
[TBL] [Abstract][Full Text] [Related]
28. Regulation of expression of mammalian gonadotrophin-releasing hormone receptor genes.
Hapgood JP; Sadie H; van Biljon W; Ronacher K
J Neuroendocrinol; 2005 Oct; 17(10):619-38. PubMed ID: 16159375
[TBL] [Abstract][Full Text] [Related]
29. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
31. Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core.
García Garayoa E; Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwe DA; Schibli R; Schubiger PA
Bioconjug Chem; 2008 Dec; 19(12):2409-16. PubMed ID: 18998719
[TBL] [Abstract][Full Text] [Related]
32. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F
J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086
[TBL] [Abstract][Full Text] [Related]
33. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
[TBL] [Abstract][Full Text] [Related]
34. GnRH analogues--agonists and antagonists.
Padula AM
Anim Reprod Sci; 2005 Aug; 88(1-2):115-26. PubMed ID: 15955640
[TBL] [Abstract][Full Text] [Related]
35. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.
Poethko T; Schottelius M; Thumshirn G; Hersel U; Herz M; Henriksen G; Kessler H; Schwaiger M; Wester HJ
J Nucl Med; 2004 May; 45(5):892-902. PubMed ID: 15136641
[TBL] [Abstract][Full Text] [Related]
36. Characterization of an intrinsically fluorescent gonadotropin-releasing hormone receptor and effects of ligand binding on receptor lateral diffusion.
Nelson S; Horvat RD; Malvey J; Roess DA; Barisas BG; Clay CM
Endocrinology; 1999 Feb; 140(2):950-7. PubMed ID: 9927328
[TBL] [Abstract][Full Text] [Related]
37. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.
Emons G; Ortmann O; Becker M; Irmer G; Springer B; Laun R; Hölzel F; Schulz KD; Schally AV
Cancer Res; 1993 Nov; 53(22):5439-46. PubMed ID: 8221683
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging.
Varasteh Z; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Sandström M; Selvaraju RK; Malmberg J; Tolmachev V; Orlova A
Bioconjug Chem; 2013 Jul; 24(7):1144-53. PubMed ID: 23763444
[TBL] [Abstract][Full Text] [Related]
39. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
[TBL] [Abstract][Full Text] [Related]
40. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
